Recently, Nigro and his colleagues screened a cohort of 786 undiagnosed patients with LGMD or nonspecific myopathic features using next-generation sequencing, and found that 33 out of 786 patients carry ANO5 mutations in both allele (either homozygous or compound heterozygous). Here, ANO5 is linked to limb-girdle muscular dystrophy.